This results first in an equilibrium state characterized by a balance between proliferation and killing of tumor cells by CD8+ T cells thereby maintaining the tumor at a subclinical stage, followed by the generation of tumor cells, which are resistant to immune rejection due to constant selective pressure of the immune system (2). This evidence concerns the gene CD8A and neoplasm.